Simcere Zaiming schließt exklusive Lizenzvereinbarung mit Roche über die weltweite Entwicklung von SIM0660

PartnershipSIM0660Positive

AI Analysis

Summary

Simcere Zaiming signed an exclusive worldwide licensing agreement with Roche for the development and commercialization of SIM0660, a trispecific therapeutic candidate.

Outcome Details

Exclusive worldwide licensing agreement for development and commercialization of SIM0660

Importance:7/10

Sentiment:

0.70

licensing agreementpartnershipSIM0660worldwide rightsdevelopmentcommercialization

Related Companies

$RHHBY

Read the original article

Published by PR Newswire Pharma on September 2, 2026 8:02 AM

Read Original